Aerie pharmaceuticals to acquire avizorex pharma to advance its dry eye program

Aerie pharmaceuticals announces agreement to acquire avizorex pharma, s.l. to advance its dry eye program.aerie pharmaceuticals inc - aerie will acquire avx pharma in an all-cash transaction.aerie pharmaceuticals inc - aerie will make an upfront payment of $10 million, subject to customary adjustments.aerie pharmaceuticals inc - company plans to commence phase 2b study in dry eye subjects in late 2020.aerie pharmaceuticals inc - avx pharma shareholders will be eligible to receive additional payments subject to achievement of certain milestones.aerie pharmaceuticals inc - planning to initiate a larger phase 2b study in late 2020 in dry eye subjects.aerie pharmaceuticals - in addition to avx-012, aerie will also be acquiring rights to other compounds targeting trpm8.
AERI Ratings Summary
AERI Quant Ranking